Brain implants show promise for depression patients who fail drug treatment
Researchers report that deep brain stimulation targeting a specific brain region provided sustained relief for two patients with treatment-resistant depression and anxiety who had exhausted medication options. The findings suggest a potential path forward for the roughly 30% of depression patients who don't respond to conventional treatments—a population that represents significant untapped demand for novel therapeutics.
Originaltitel: Deep brain stimulation in the bed nucleus of stria terminalis and medial forebrain bundle in two patients with treatment‐resistant depression and generalized anxiety disorder: a long‐term follow‐up
<p>This case report presents positive outcomes from deep brain stimulation (DBS) targeting the bed nucleus of the stria terminalis (BNST) in two patients with treatment-resistant depression and generalized anxiety disorder. DBS effects in the medial forebrain bundle (MFB) area were unclear. Further research into DBS's efficacy when comorbid anxiety is present is required.</p>